Ligand validation:8FGF

XVO: 6-(2-{5-[2-(dimethylamino)ethyl]-2,3-difluorophenyl}ethyl)pyridin-2-amine

XVO is a Ligand Of Interest in 8FGF designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8FGF_XVO_A_803	16%	24%	0.308	0.877	0.41	2.62	-	8	0	0	100%	1
8FGF_XVO_B_803	2%	41%	0.634	0.902	0.36	1.88	-	6	4	0	100%	0.59
8FG9_XVO_B_803	25%	42%	0.262	0.901	0.46	1.75	-	5	1	0	100%	1
8FGN_XVO_D_503	50%	41%	0.168	0.918	0.49	1.77	-	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.